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Abstract Optimal healing after myocardial infarction
requires not only the induction of inflammation, but also its
timely resolution. In patients, 30 days post myocardial
infarction, circulating monocytes have increased expres-
sion of Semaphorin3A (Sema3A) as compared to directly
after admission. This increased expression coincides with
increased expression of Cx3CR1—a marker of non-clas-
sical monocytes that are important for immune resolution
hence proper wound healing. In mice, the expression of
Sema3A also increases in response to myocardial ischemia
being expressed by infiltrating leukocytes. Comparing
Sema3A heterozygote (HZ) and wild type (WT) mice post
myocardial infarction, revealed increased presence of
leukocytes in the cardiac tissues of HZ mice as compared
to WT, with no differences in capillary density, collagen
deposition, cardiomyocyte surface area, chemokine—or
adhesion molecules expression. Whilst infarct sizes were
similar 14 days after myocardial infarction in both
genotypes, Sema3A HZ mice had thinner infarcts and
reduced cardiac function as compared to their WT litter-
mates. In vitro experiments were conducted to study the
role of Sema3A in inflammation and resolution of inflam-
mation as a potential explanation for the differences in
leukocyte recruitment and cardiac function observed in our
in vivo experiments. Here, recombinant Sema3A protein
was able to affect the pro-inflammatory state of cultured
bone marrow derived macrophages. First, the pro-inflam-
matory state was altered by the induced apoptosis of
classical macrophages in the presence of Sema3A. Second,
Sema3A promoted the polarization of classical macro-
phages to resolution-phase macrophages and enhanced
their efferocytotic ability, findings that were reflected in the
infarcted cardiac tissue of the Sema3A HZ mice. Finally,
we demonstrated that besides promoting resolution of
inflammation, Sema3A was also able to retard the migra-
tion of monocytes to the myocardium. Collectively our
data demonstrate that Sema3A reduces cardiac inflamma-
tion and improves cardiac function after myocardial
infarction by promoting the resolution of inflammation.
Keywords Myocardial infarction  Inflammation  Heart
failure  Semaphorin3A
Introduction
The improved clinical management of acute myocardial
infarction (AMI) has resulted in a substantial reduction in
mortality, yet this has led to the increased prevalence of
heart failure and represents a huge socio-economic burden
[23]. Cardiac inflammation in response to ischemia is key
for repairing the damaged myocardium yet sustained
inflammation results in adverse remodeling and
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consequently poor cardiac function and prognosis [17, 35].
Thus, post-infarct inflammation promotes infarct healing
granted in its containment via the timely clearance of
recruited pro-inflammatory leukocytes [16, 32]. The signals
that recruit pro-inflammatory monocytes (LyChi) has been
well characterized [30], but little is known about the factors
that switch off inflammation [2]. Recent studies have
introduced the possibility that the transition to repair is not
solely driven by the recruitment of reparative monocytes
from the circulation, but suggest that local factors may be a
key in promoting resolution from within the heart [18].
Understanding the molecular mechanisms that underline
the transition to repair is important in designing new
effective therapeutic strategies.
Semaphorin3A (Sema3A) is a secreted glycoprotein first
identified as a chemo-repellent during axonal guidance [26],
and crucial for embryonic development [3, 10]. In addition to
its involvement in cell motility [12] and neuronal-vascular
growth [15, 37], Sema3A has also been ascribed with tumor-
reducing capacities [8] and anti-inflammatory properties
during dermatitis [31], autoimmune arthritis [6] and kidney
injury [33]. Sema3A is also a potent suppressor of T-lym-
phocyte activity [7, 24, 25, 29]. In the failing heart, Sema3A
has been shown to be expressed by cardiomyocytes and to
contribute to the sympathetic denervation in chronic heart
failure [9], yet its function during cardiac inflammation and
wound healing is unknown. In this study,we identify Sema3A
as a key factor expressed by infiltrating leukocytes that pro-
mote the resolution of inflammation thereby facilitating car-
diac wound healing and improving cardiac function.
Materials and methods
Human monocyte samples
We prospectively collected blood samples from 11 patients
with acute coronary syndrome (ACS) on admission, at
3 days and at 30 days. Patients with cardiogenic shock,
end-stage renal disease (eGFR\15 ml/min), inflammatory
disease or history of malignancy were excluded. Patient
characteristics can be found in Supplementary Table 1. The
study protocol was approved by the institution’s ethical
committee (Ethical Committee ML8525, Belgian trial no.
B322201214942, S54129, September 2012) and all patients
provided informed consent. During hospitalization, high
sensitivity troponin T and hsCRP were measured. Mono-
cytes were isolated by Ficoll density gradient centrifuga-
tion of citrated whole blood, followed by CD14? magnetic
beads selection of the mononuclear fraction (Miltenyi).
Total RNA was extracted using the Qiagen miRNeasy mini
kit, and the RNA yield and integrity was determined with
NanoDrop spectrophotometer.
Animals
For this study Sema3A heterozygote knock out (HZ) mice
and wild type (WT) mice were used, and were a gift fromDr.
J. Verhaagen, Netherlands Institute for Neuroscience,
Amsterdam. As Sema3A is a vital protein for proper
embryonic development of the nervous system [3], we
noticed that the born homozygote knockout mice presented
with severe retardation and diedwithin a few days after birth,
as was also described by Taniguchi et al. that generated these
Sema3A knock out mice [36]. Therefore, we bred the colony
by crossing Sema3A wild type with Sema3A heterozygote
mice, to prevent the birth of these severely impaired Sema3A
knock out mice. All animal experiments were approved by
theAnimal Care Committees ofMaastricht University (DEC
2007-051/2013-055) and Leuven University (ECD
232/2013). Mice were age-matched at the start of the
experimental protocol and experiments were performed
using both male and female mice at random.
Myocardial infarction model
Myocardial infarction was induced by ligation of the left
anterior descending artery after subcutaneously anaes-
thetizing the animals with a mix of ketamine xylazine,
respectively, 100 and 5 mg/kg subcutaneously in a volume
of 0.1 ml 0.9% NaCl/10 g bodyweight. After anesthetizing,
the animals were intubated with a 20-gauge intra-tracheal
cannula. Rectal temperaturewas constantlymeasured during
the procedures. After shaving the animals, an incision was
made microscopically. As a clear view of the left coronary
artery is reached, the left anterior descending artery was
ligated. After successful ligation of the left anterior
descending artery, the wound was closed with soluble stit-
ches. Sham operations included all procedures except liga-
tion of the left anterior descending artery. Echocardiography
was performed prior to killing at 2 weeks post myocardial
infarction. Heart, lung, kidney, and liver weights were
measured. The left ventriclewas separated from the heart and
divided for histological and molecular analyses. Heart tissue
for molecular analyses was immediately placed in liquid
nitrogen, and stored at -80 C.
Echocardiography
To gain echocardiographic images, the animals were
anesthetized by ventilation with isoflurane 3–4%. The
anesthesia was maintained by artificially ventilating with
a mixture of O2 and N2O [1:2 (vol/vol)] to which
isoflurane 1.5–2.5% was added. Standard views were
obtained in 2-D as well as M-mode by transthoracic
echocardiography using a 12 MHz probe (Hewlett
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Packard, Amsterdam, The Netherlands) on a Visual
Sonics echocardiograph.
FACS analysis
Peripheral blood samples were analyzed using a FACS
CantoII flow cytometer (Becton Dickenson (BD), San
Diego, CA, USA). Cells were first incubated with anti-
CD16/32 (eBioscience, San Diego, CA, USA) to block Fc
receptor binding. CD45? leukocytes subpopulations were
defined as follows: T lymphocytes (CD45?, CD3?, B220-),
B lymphocytes (CD45?, CD3-, B220?), Granulocytes
(CD45?, CD3-, B220-, CD11b?, Ly6G?), and Monocytes
(CD45?, CD3-, B220-, CD11b?, Ly6G-, CD11b?, Ly6C-
or?). Absolute counts were determined with BD True-
countTM tubes according to the manufacturer’s instructions.
Staining and immunohistochemistry
Hearts were perfused from the apex with phosphate buf-
fered saline (PBS), fixed overnight and processed the fol-
lowing day, before being embedded in paraffin. The
embedded left ventricle was cut longitudinally in 4 lm
sections to optimally demonstrate the infract area. Sec-
tions were stained with hematoxylin/eosin for detection of
infarct size and thickness. Collagen was stained on cardiac
sections using Sirius Red, and the amount of collagen was
quantified. Immunohistochemistry on paraffin sections was
performed according to protocol using antibodies against
CD45 (leukocytes), CD68 or Mac-3 (macrophages), CD31
(endothelial cells), and Sema3A and quantified in the
infarct area. Images were acquired using Leica Qwin image
processing software (Leica, Germany).
Western blot
Tissues were lysed in RIPA SDS (50 mM Tris–HCl,
150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1%
NP40, Proteinase Inhibitor Cocktail, Roche, 11697498001
and 0.5 mM orthovandate) after which the protein concen-
tration was determined using a Micro BCA Protein assay kit
(Thermo Scientific, lot# MJ162220). Samples were diluted
to a final concentration of 2 lg/ll after which two times
sample buffer (25 ml 0.5 MTris–HCl, 20 ml 100%glycerol,
20 ml, 20% SDS, 35 ml Aqua Dest with 1:10 b-mercap-
toethanol) was added to protein samples 1:1. Cells were
directly lysed in sample buffer. For western blot analyses
20 lg protein was loaded on a 10% gel (4 ml Aqua Dest,
3.3 ml 30% AcrylAmide, 2.5 ml 1.5 M Tris–HCl pH 8.8,
0.1 ml 10% SDS, 0.004 ml TEMED). SDS PAGE was per-
formed at 150 V for approximately 90 min after which the
gel was transferred to a PVDF membrane by blotting at
200 mA for 2 h. Membranes were blocked with 3.5%
Protifar for 1 h. Overnight primary antibody incubation was
performed in 5% BSA with antibodies against Sema3A
(Abcam, ab23393), Cleaved Caspase 3 (Cell Signaling
Technology (CST) #9664S), BCL2 (Cell Signaling Tech-
nology (CST) #2870S), GAPDH (Millipore, MAB374).
RT-PCR
Real-time reverse transcriptase-polymerase chain reaction
(RT-PCR or QPCR) analysis was performed (Bio-Rad,
Maastricht, The Netherlands) to describe transcript levels
of Sema3A (forward primer CGGTGGCTCAATGATCCT
AGA, reverse primer TTTGTCATCTTCAGGGTTGT
CACT at 63.9 C), CVB3 (forward primer ACGAATCC
CAGTGTGTTTTGG, reverse primer TGCTCAAAAACG
GTATGGACAT at 63.9 C), GAPDH (forward primer
GGTGGACCTCATGGCCTACA, reverse primer CTCT
CTTGCTCAGTGTCCTTGCT at 63.9 C), VCAM1 (for-
ward primer CCGGCATATACGAGTGTGAA, reverse
primer GATGCGCAGTAGAGTGCAAG at 63.9 C),
ICAM1 (forward primer TGGAGACGCAGAGGA
CCTTA, reverse primer CGCTCAGAAGAACCACCTTC
at 63.9 C), PECAM1 (forward primer CCCCCAGAA-
CATGGATGTAG, reverse primer GTCTCTGTGG
CTCTCGTTCC at 63.9 C), MCP1 (forward primer
ACCAGCAGCAGGTGTCCC, reverse primer GCACA-
GACCTCTCTCTTGAGCTT at 63.9 C), CCL7 (forward
primer ACCAGTAGTCGGTGTCCCTG, reverse primer
AGGCTTTGGAGTTGGGGTTTTCA at 63.9 C), IL6
(forwardprimerCAAAGCCAGAGTCCTTCAGAG, reverse
primer GCCACTCCTTCTGTGACTCC at 63.9 C). The
primers sequences of these genes were determined by NCBI
software analysis of Primer BLAST. Details of sequences and
thermal cycle conditions are according to protocol. Data were
acquired and analyzed using IQ5 software (Bio-Rad, Maas-
tricht, The Netherlands).
Monocyte isolation from murine spleens
Spleens were collected from Sema3A WT and HZ mice
and cut into small pieces. With the back of a syringe the
spleen was pushed through a 70 lm Cell Strainer (BD
Falcon), while rinsing with ice cold PBS. After collecting
the cells in a 50 ml tube they were spun down. A single cell
suspension was obtained by dissolving the cells in 1 ml ice
cold PBS which was followed by manual counting of cell
with the use of a Burker Turk Counting chamber. Cells
were spun down again and dissolved in the appropriate
volume of PBS for MACS miltenyi monocyte isolation.
Monocytes were isolated using mouse CD11b Microbeads
(Miltenyi) and MACS LS separation columns (Miltenyi)
according to manufacturer’s protocol. After isolation,
monocytes were labeled using CFSE (CellTraceTM CFSE
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Cell Proliferation Kit) according to manufacturer’s
protocol.
Chemotaxis assay or Boyden chamber assay
250,000 monocytes were seeded onto the upper chamber
FluoroBlok inserts (Falcon, Fluorescence Blocking PET
track-etched membrane 24-well format) in 200 ll, while
700 ll of phenol free RPMI containing either Sema3A or
fMLP was filled into the lower one. Monocyte migration
was monitored by acquiring six microscopic images per
well, avoiding the center and edges of the well. These
images were taken at 1, 2 and 4 h for spontaneous migra-
tion, and 4 h for comparing WT and HZ monocyte
chemotaxis. Images were analyzed using ImageJ software.
Bone marrow derived macrophages isolation
Both tibia and femurs were collected form Sema3AWTmice
in ice cold PBS and stripped from muscles. After placing the
stripped bones in 70% Ethanol for approximately 45 s they
washed again with PBS after which the ends were cut off and
the inner bone marrow was flushed out with a 25G syringe
filled with cold PBS. After flushing all the bones a single cell
suspension was obtained by pushing the suspension through a
100 lm Nylon cell strainer. Cells were spun down at
1200 rpm and placed in bacterial plates in RPMI 1640 with
15% LCM for culture and differentiation for approximately
8–10 days, adding or replacing medium every 2–3 days.
Experiments were performed after differentiation in
8–10 days. Cells were counted using a Burker Turk cell
counting chamber and 400,000 cells seeded in 12-wells plates.
The cells were stimulated the next day after the cells had
adhered to the plastic. At the end of the experiments the cells
were directly harvested in RLT buffer for RNA isolation, and
sample buffer for immunoblotting.
Efferocytosis assay
Macrophages (200,000) were seeded in 24-well tissue
culture plate and polarized with either 10 ng/ml LPS and
10 ng/ml INF-c or 10 ng/ml IL-10 with and without pres-
ence of 150 ng/ml recombinant Sema3A, produced in a
Chinese Hamster Ovary cell line (R&D systems, Cat. No.
5926-S3-025) [25, 34]. Jurkat-cells were cultured in
10 mm dishes in RPMI 1640 with 10% FBS. Jurkat-cells
were stained with CFSE (CellTraceTM CSFE (Cat. No.
C34554), Life Technologies), according to the protocol
supplied by the manufacturer. Briefly, cells were spun
down and incubated with CFSE labeling solution (1:1000
in warm PBS) for approximately 15 min at 37 C. Subse-
quently, they were re-pelleted and incubated in fresh pre-
warmed medium for another 30 min. After washing the
cells with PBS they were counted and re-suspended in
10 ml medium in a 10 mm dish. Irradiating the cells for
5 min with 1200 9 100 lJ/cm2 induced apoptosis in the
Jurkat-cells. To ensure homogenous exposure the plate was
swirled every 60 s. The irradiated cells were incubated for
another 2 h after which they were seeded in a 1:1 ratio on
top of the seeded macrophages and incubated with the
polarized macrophages for approximately 45 min. After-
wards they were removed and the macrophages washed
twice with ice cold PBS and fixed with 1%
paraformaldehyde for 10 min. Cells were then washed
again with PBS after which images were taken
immediately.
Statistical analysis
Data were expressed as mean ± SEM. No repeated mea-
surements were performed. Echocardiograph measure-
ments and histological and molecular analysis in sham
operated and infarct groups were performed in independent
groups. Normal distribution of all continuous variables was
tested using the Kolmogorov–Smirnov test. An unpaired
t test was used in most of the comparisons when groups
passed the normality test. However, a Mann–Whitney test
was used when the standard deviations of two groups were
significantly different. A two-sided p value \0.05 was
considered statistically significant.
Results
Sema3A expression increases during myocardial
infarct healing
Sema3A gene expression increased progressively in cir-
culating monocytes from patients post myocardial infarc-
tion and reached significance at day 30 (Fig. 1a).
Interestingly these increases were also observed in the gene
expression of Cx3CR1 (Fig. 1b)—a marker of reparative
non-classical monocytes in humans [39]. In the murine
model of myocardial infarction, 3 days after myocardial
infarction Sema3A gene expression increased significantly
in the areas bordering the infarcted tissue (p\ 0.05),
returning back to baseline levels after 14 days (Fig. 1c,
p\ 0.005). In the infarcted area expression of Sema3A
transcripts increased significantly at 14 days after infarc-
tion (Fig. 1d, p\ 0.001). Concomitantly, Sema3A
expression was observed predominantly in the border zone
and not in the infarcted area at 3rd day (Fig. 1e), whilst at
14th day Sema3A expression was concentrated within the
infarct (Fig. 1f). Finally, Sema3A was detected on infil-
trated leukocytes (CD45? cells) and specifically on the
resident macrophage population (MAC-3?ve cells).
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Fig. 1 Sema3A expression
increases during infarct healing
and is present on macrophages.
a, b Increased expression of
Sema3A and Cx3CR1 following
myocardial infarction in
circulating monocytes from
patients at day 3 and significant
increases at day 30 post
admission (p = 0.001 and 0.04,
n = 11). c Sema3A gene
expression increased
significantly in the border zone
3 days after myocardial
infarction in the murine model
(*p\ 0.05, **p\ 0.01, n C 4).
Fourteen days after ischemic
injury, the expression also
increased in the infarcted area
(***p\ 0.001, n C 4). d The
expression of Sema3A in both
the infarct and border zone was
confirmed by
immunohistochemistry. Where
Sema3A expression
predominated in the border zone
3 days after MI, 14 days after
MI the increased expression in
the infarct became more
apparent (e). RNA expression
decreased to baseline levels in
the infarct border zone at
14 days post-MI.
Counterintuitively, immuno-
histochemical staining still
showed substantial Sema3A
presence at this time. This
apparent discrepancy might be
indicative of the slower rate of
protein degradation.
Immunofluorescence further
revealed Sema3A location on
leukocytes and macrophages (f).
Scale bar 50 lm
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Sema3A reduces cardiac inflammation
after myocardial injury
Sema3A knockout mice are embryonically lethal yet the
heterozygous mice (HZ) are viable and express approxi-
mately half the amount of Sema3A mRNA at baseline in
the heart in comparison to their wild type (WT) littermates
(1.22 ± 0.05 in WT compared to 0.62 ± 0.11 in HZ,
arbitrary units) [3]. Sema3A WT and HZ mice were sub-
jected to the mouse model of myocardial infarction
(Fig. 2a). Though mortality and infarct size between both
genotypes were similar (Fig. 2a–c), fractional shortening
was significantly reduced in Sema3A HZ as compared to
WT mice (Fig. 2d; Table 1; p\ 0.05). Furthermore, no
significant differences in collagen content, cardiomyocyte
hypertrophy or capillary density were seen within the
infarcted area between genotypes (Table 2). However, the
amount of CD45-positive leukocytes was significantly
greater in Sema3A HZ than in WT mice in the border zone
at 3rd day, but did not differ in the infarct zone (p\ 0.005,
Fig. 2 Sema3A regulates inflammation during infarct healing.
a Coronary artery occlusion in Sema3A WT and HZ mice did not
result in a difference in mortality. b, c Despite comparable infarct
sizes between both groups, Sema3A HZ mice showed worse cardiac
function with decreased fractional shortening (d, *p\ 0.05, n C 13).
The number of recruited immune cells was determined by immuno-
histochemical staining for both the infarct and the border zone, 3 and
14 days after MI. e Sema3A HZ had more leukocytes in the border
zone 3 days after ischemic injury as compared to WT (**p\ 0.01,
n C 4). f Fourteen days after infarction the increased presence of
leukocytes in Sema3A HZ mice was also apparent in the infarct area
(***p\ 0.001, n C 9). All experiments were repeated at least twice
Table 1 Echocardiography at
baseline and 14 days post-MI
Sham 14 days post-MI
WT (n = 8) HZ (n = 10) WT (n = 13) HZ (n = 14)
IVSd (mm) 0.8 ± 0.02 0.8 ± 0.04 0.6 ± 0.06 0.5 ± 0.05£
LVPWd (mm) 0.8 ± 0.02 0.8 ± 0.02 0.8 ± 0.04 0.7 ± 0.04
LVIDd (mm) 3.9 ± 0.07 3.9 ± 0.07 4.9 ± 0.2£ 4.6 ± 0.1£
LVIDs (mm) 2.7 ± 0.05 2.8 ± 0.07 4.1 ± 0.2£ 4.0 ± 0.1£
FS (%) 30 ± 0.5 30 ± 0.8 17 ± 1.9£ 11 ± 1.6*,£
Heart rate (bpm) 543 ± 55 576 ± 27 580 ± 22 597 ± 15
IVSd interventricular septum diastole, LVPWd left ventricular posterior wall diastole, LVIDd left ventricular
internal diameter diastole, LVIDs left ventricular internal diameter systole, FS fractional shortening, MI
myocardial infarction
£ p\ 0.05 sham vs. MI
* p\ 0.05 Sema3A WT vs. HZ post-MI
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Fig. 2e, f). Inversely, at 14 days post-MI a significant
greater number of CD45-positive leukocytes were observed
in the infarct zone of Sema3A HZ mice as compared to WT
mice, but not in the border (p\ 0.001, Fig. 2g, h). A
similar increase in inflammation was seen in Sema3A HZ
mice compared to WT when using the non-sterile model
for cardiac injury of Coxsackie B3 induced viral
myocarditis, where Sema3A expression could also be
found on macrophages (Supplementary Figure 1). Finally,
more macrophages were present in the infarcted area of the
Sema3A HZ mice as compared to WT mice at 14th day
(p\ 0.005; Table 2).
Sema3A does not induce a difference in monocyte
activation and recruitment
Flow cytometric analysis was performed to assess the
distribution of leukocytes in the circulation in the Sema3A
HZ mice as compared to WT mice without cardiac injury,
with no significant changes observed (Fig. 3a). Further-
more, decreased Sema3A levels did not result in significant
changes in the amount of leukocyte subsets present in the
circulation 3 days after myocardial infarction (Fig. 3b). As
increased monocytosis could not explain the increased
presence of macrophages in the infarcted area, the cardiac
expression of adhesion molecules and chemokines known
to influence monocyte recruitments were measured in
Sema3A HZ and WT mice. No differences were found in
the expression of adhesion molecules VCAM1, ICAM1
and PECAM1 between Sema3A WT and HZ mice
(Fig. 3c–e). Furthermore, monocyte chemoattractant
MCP1 and CCL7 as well as pro-inflammatory cytokine
interleukin-6 did not show any differences in mRNA
expression between both genotypes (Fig. 3f, g).
Sema3A crucial for constraining monocyte
recruitment and inducing pro-inflammatory
macrophage apoptosis
In vitro chemotaxis experiments explored whether Sema3A
itself could regulate monocyte migration. Isolated primary
monocytes from HZ mice migrated significantly faster
towards the chemoattractant fMLP than WT monocytes
(Fig. 4a; p\ 0.001). In parallel, the presence of recombi-
nant Sema3A protein in the bottom of a Boyden chamber
impeded the migration of WT monocytes (p\ 0.05;
Fig. 4b). We further addressed the effect of Sema3A on
macrophage function, as timely resolution of cardiac
inflammation is a vital step in proper cardiac healing in
response to ischemia. Therefore, bone marrow derived
macrophages were polarized towards an anti-inflammatory
(alternative-M/, M2) phenotype or towards a pro-inflam-
matory (classical-M/, M1) phenotype [27], prior to stim-
ulation with recombinant Sema3A. Stimulation with
recombinant Sema3A of polarized macrophages resulted in
a visible decrease in cell density in the pro-inflammatory
classical-M/ (M1), but not in the alternative-M/ (M2)
(Fig. 4c). Furthermore, stimulation with Sema3A signifi-
cantly increased the levels of apoptotic markers cleaved
caspase-3 (CC3) and BCL2 in the classical-M/, but not in
alternative-M/ (Fig. 4d, e; p\ 0.01). Concomitantly,
Sema3A HZ mice had no detectable CC3 protein expres-
sion in the infarcted area, which was detectable in the
infarcts of WT mice at 14th day post-MI (Fig. 4f).
Sema3A promotes the transition of classically
activated macrophages towards resolution
Resolution-phase macrophages are neither classical-M/
nor alternative-M/, but a hybrid of both, and are
Table 2 Biometric and histological data at baseline, 3 and 14 days post-MI in the infarct zone
Sham 3 days post-MI 14 days post-MI
WT (n = 7) HZ (n = 8) WT (n = 9) HZ (n = 9) WT (n = 9) HZ (n = 10)
HW/BW (mg/kg) 4.6 ± 0.2 4.5 ± 0.2 5.2 ± 0.3 6.0 ± 0.4 5.1 ± 0.3 5.3 ± 0.2
Lung/BW (mg/kg) 7.0 ± 0.5 7.6 ± 1.0 7.8 ± 0.3 8.5 ± 0.5 10.0 ± 1.2 9.1 ± 0.7
Infarct size (%) n.a. n.a. 45 ± 2.3 42 ± 3.1 52 ± 3.4 51 ± 3.2
Infarct thickness (lm) n.a. n.a. 569 ± 32 600 ± 74 229 ± 16 171 ± 12*
Collagen (%) n.a. n.a. n.a. n.a. 60 ± 2 61 ± 3
Microvessels (vessels/mm2) n.a. n.a. n.a. n.a. 239 ± 34 231 ± 7
Leukocytes (cells/mm2) 48 ± 11 42 ± 12 153 ± 64 175 ± 52 239 ± 18 378 ± 26***
Macrophages (cells/mm2) n.a. n.a. n.a. n.a. 230 ± 62 481 ± 42*
Myocyte surface area (lm2) n.a. n.a. n.a. n.a. 339 ± 20 338 ± 18
HW/BW heart weight/body weight, Lu/BW lung weight/body weight, MI myocardial infarction, n.a. not applicable
* p\ 0.05 Sema3A WT vs. HZ post-MI
*** p\ 0.0001 Sema3A WT vs. HZ post-MI
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characterized by the expression of inducible cyclooxyge-
nase (COX2) and iNOS [4]. Stimulation of classical-M/
(M1) with recombinant Sema3A significantly increased the
transcript expression of M/-markers iNOS, IL-10, YM-1
and COX-2 (Fig. 5a–d). Furthermore, Sema3A stimulation
increased COX2 protein levels in the pro-inflammatory
classical-M/ (M1), but not in the alternative-M/ (M2,
Fig. 5e). To demonstrate that Sema3A not only shifts the
phenotype of classical-M/ towards ‘resolution-M/’, the
function of these macrophages to clear inflammation (ef-
ferocytosis)—a crucial step in correct infarct healing—[38]
was assessed. Alternative-M/ are better at clearing dying
A B
C D E
F G H
Fig. 3 Sema3A does not regulate leukocyte activation, adhesion
molecule and chemokine expression central to leukocyte transmigra-
tion. a Flow cytometric analysis of circulation leukocytes did not
reveal any differences in the distribution of leukocyte subsets in the
Sema3A HZ mice (n = 4) as compared to WT mice (n = 5). b There
were no differences between Sema3A HZ and WT mice in the
number of leukocytes in the circulation 3 days after myocardial
infarction (n = 4 vs. 6, respectively). c–e RNA expression of
adhesion molecules VCAM1, ICAM1 and PECAM1 is similar in
Sema3A WT compared to HZ mice 14 days after myocardial
infarction (p = ns, n C 6). f–h Further, equal RNA expression of
monocyte chemoattractant MCP1 and CCL7 and pro-inflammatory
cytokine IL6 was found in Sema3A WT compared to HZ mice
14 days after myocardial infarction (p = ns, n C 6)
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Fig. 4 Sema3A inhibits chemotaxis and promotes pro-inflammatory
macrophages clearance by inducing apoptosis. The migratory capac-
ity of isolated splenic monocytes was assessed using a Boyden
Chamber Assay for chemotaxis. a The migratory capacity of Sema3A
WT and HZ monocytes towards the chemoattractant fMLP1 revealed
the decreased migratory capacity in Sema3A WT monocytes as
compared to HZ (*p\ 0.05, ***p\ 0.001, n = 4). b Sole presence
of Sema3A in the lower chamber significantly confirmed decreased
migration by inhibiting spontaneous migration of monocytes
(*p\ 0.05, n = 4). c Bone marrow derived macrophages were
isolated and polarized for 24 h in the presence of either IL-10 or LPS
in combination with INFc towards M2 and M1, respectively.
Stimulation of M1 with Sema3A resulted in a decreased cell density
as compared to M2 cells. Western blot analyses (d) and quantification
(e, f) for Cleaved Caspase 3 (CC3) and BCL-2 revealed the decreased
cell density in the M1 as a consequence of increased apoptosis
(**p\ 0.01, n = 3). Western blot analysis (g) and quantification
(h) revealed clear presence of CC3 in WT myocardial infarcts that
could not be detected in HZ mice (n = 6). All experiments were
repeated at least twice
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cells than classical-M/; however, in the presence of
recombinant Sema3A classical-M/ increased significantly
their efferocytotic capabilities (Fig. 5f, g; p\ 0.01). In
parallel, COX2 levels were significantly lower in infarcted
cardiac tissue of Sema3A HZ as compared to WT mice,
despite higher levels of CD68 (Fig. 5h, i; p\ 0.05).
Discussion
The present study demonstrates that Sema3A is important
for proper myocardial wound healing. It is the first study to
demonstrate a role for Sema3A in promoting the resolution
of inflammation after AMI which may be in line with the
increased expression of Sema3A in monocytes of human
subjects following myocardial infarction. The recruitment
of monocytes is of critical importance in the wound healing
response following myocardial injury, but restraining the
flow of monocytes is equally needed to avoid excessive
inflammation that may contribute to adverse cardiac
remodeling [13, 20]. Sema3A regulates the inflammatory
phase following myocardial injury by curbing the flow of
recruited cells, but also by promoting the transition of
classical-M/ to resolution or alternative-M/.
Recently, Hou et al. demonstrated that Sema3A induces
vascular permeability in cerebral ischemia-induced brain
damage via the neuropilin-2/VEGR1 receptor complex
[21]. In addition, Sema3A also competes with VEGF,
hence affects vascular permeability during angiogenesis
[1]. Despite cardiac ischemia initiating changes in vascular
permeability and angiogenesis, the reduced Sema3A in the
HZ mice did not affect these processes. Sema3A has not
previously been ascribed a role in resolving inflammation,
though Sema3A has been shown to limit the recruitment of
tumor-associated macrophages, restricting angiogenesis
and restoring antitumor immunity [5]. In line with previous
work on Sema3A and macrophages [22], this study reveals
that Sema3A promotes the resolution of cardiac inflam-
mation by regulating monocyte/macrophage function in
four ways: (1) limiting the recruitment of monocytes, (2)
promoting the apoptosis of classical-M/ (M1) and (3)
stimulating their transition to resolution-phase
Fig. 5 Immune resolution is promoted by Sema3A via selective
induction of a phenotypic switch in pro-inflammatory macrophages
towards resolution-phase-macrophages. Bone marrow derived macro-
phages were isolated and polarized for 24 h towards M1 with and
without the presence of Sema3A. a–c The expression of iNOS, IL-10
and YM1 increased significantly in response to stimulation with
Sema3A (*p\ 0.05, ***p\ 0.001, n = 3). Interestingly, the addi-
tion of Sema3A resulted in a marked induction of COX2 transcript
levels (d) and protein levels (e) (***p\ 0.001, n = 3). Clearance of
apoptotic cells by means of efferocytosis was assessed in vitro.
Fluorescently labeled apoptotic Jurkat-cells were fed to M2 and M1
with and without the presence of Sema3A. As expected, M2 were
significantly better at clearing apoptotic Jurkat-cells than M1 (f, g).
Remarkably, addition of Sema3A to M1 resulted in a significant
increase in the percentage of efferocytotic cells (f, g) (**p\ 0.01,
n = 3). All experiments were repeated at least twice
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macrophages, thereby (4) enhancing efferocytosis (Fig. 6).
Though it is accepted that alternative-M/, along with
resolution-M/ are critical for the transition to repair, the
authenticity of well-defined M1 and M2 macrophage
populations in vivo is still of ongoing debate [28]. Still,
while little is known about the local factors that mediate
the shift to repair, recently IRF5 and NR4a-1 were shown
to be critical in promoting the transition of macrophages
towards resolution [11, 18]. However, more is known about
the signals coming from T-cell subsets that promote repair
such as IL-13 [19] and thymosin beta4 [14]. Here we show
that Sema3A is vital for regulating cardiac mono-
cyte/macrophage function in response to ischemic induced
myocardial injury. Despite additional experiments, we
were not able to provide substantial evidence that will
allow us to ascribe the effect of Sema3A in response to
ischemic induced myocardial injury exclusively to mono-
cytes/macrophages. By encouraging a shift towards
immune resolution, Sema3A helps to maintain cardiac
function. Sema3A may, therefore, be of therapeutic value
not only as an anti-inflammatory agent in autoimmune
diseases and cancer, but potentially in preventing the
development of heart failure by limiting adverse cardiac
remodeling.
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